Showing results (101-110 of 230) with videos related to
Sort By:
Pageof 23
European Heart Journal|September 11, 2019
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarctionPernille G Thrane, Steen D Kristensen, Kevin K W Olesen, et al.JACC. Cardiovascular Interventions|August 21, 2010
3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classificationTakayuki Okamura, Yoshinobu Onuma, Héctor M García-García, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 11, 2013
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trialLisbeth Antonsen, Per Thayssen, Henrik S Hansen, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart RegistryLisette Okkels Jensen, Hans Henrik Tilsted, Per Thayssen, et al.American Heart Journal|December 13, 2006
Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)Leif Thuesen, Henning Kelbaek, Lene Kløvgaard, et al.Cardiology|November 14, 2008
Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudyMartin Busk, Steen D Kristensen, Klaus Rasmussen, et al.BMC Cardiovascular Disorders|March 21, 2012
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)Troels Thim, Michael Maeng, Jens Flensted Lassen, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trialPatrick W Serruys, Peter Ruygrok, Jörg Neuzner, et al.The American Journal of Cardiology|June 24, 2008
Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitusLisette Okkels Jensen, Michael Maeng, Gary S Mintz, et al.Journal of Electrocardiology|November 6, 2008
ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarctionChristian Juhl Terkelsen, Anne Kjer Kaltoft, Bjarne Linde Nørgaard, et al.Pageof 23